| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
6 |
| issn |
1176-6328 |
| issueIdentifier |
2 |
| pageRange |
481-6 |
| publicationName |
Neuropsychiatric Disease and Treatment |
| startingPage |
481 |
| bibliographicCitation |
Nagamine T. Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients. Neuropsychiatr Dis Treat. 2008 Apr;4(2):481–6. PMID: 18728746; PMCID: PMC2518388. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dcf367dad5d5a50f81913895144f9bd4 |
| date |
200804 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC2518388
https://doi.org/10.2147/ndt.s2619
https://pubmed.ncbi.nlm.nih.gov/18728746 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33193
https://portal.issn.org/resource/ISSN/1176-6328 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a49b9f3c3dc6ef6a475a73c256cc4df3
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e |